ArticleMolecules (Basel, Switzerland)2020
Identification of Novel Chemical Entities for Adenosine Receptor Type 2A Using Molecular Modeling Approaches.
Abstract read
In one paragraph
Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Identification of Potential Candidates with Antimicrobial Activity Against Antibiotic-ResistantInternational journal of molecular sciences · 2026Article
- Computational Identification of Potential Novel Allosteric IHF Inhibitors Using QSAR Modeling to Inhibit Plasmid-Mediated Antibiotic Resistance.International journal of molecular sciences · 2026Article
- Synthesis, QSAR Study and Pharmacological Evaluation of Novel Triazolidine-2-thione Analogues as Antimicrobial, Anti-inflammatory and Antioxidant Agents.Combinatorial chemistry & high throughput screening · 2026Article
- Identification of Potential Pteridin Reductase-1 Inhibitors for the Treatment of Leishmaniasis: A Bioinformatics Approach.Pharmaceuticals (Basel, Switzerland) · 2025Article
- General structure-activity relationship models for the inhibitors of Adenosine receptors: A machine learning approach.Molecular diversity · 2025Article
- Multivariate QSAR, similarity search and ADMET studies based in a set of methylamine derivatives described as dopamine transporter inhibitors.Molecular diversity · 2024Article
- Rational Approach toward COVID-19's Main Protease Inhibitors: A Hierarchical Biochemoinformatics Analysis.International journal of molecular sciences · 2024Article
- Development of Potential Multi-Target Inhibitors for Human Cholinesterases and Beta-Secretase 1: A Computational Approach.Pharmaceuticals (Basel, Switzerland) · 2023Article
- Analgesic Activity of 5-Acetamido-2-Hydroxy Benzoic Acid Derivatives and an In-Vivo and In-Silico Analysis of Their Target Interactions.Pharmaceuticals (Basel, Switzerland) · 2023Article
- Hierarchical Virtual Screening of Potential New Antibiotics from Polyoxygenated Dibenzofurans againstPharmaceuticals (Basel, Switzerland) · 2023Article
- Docking covalent targets for drug discovery: stimulating the computer-aided drug design community of possible pitfalls and erroneous practices.Molecular diversity · 2023Review
- Design and Identification of Inhibitors for the Spike-ACE2 Target of SARS-CoV-2.International journal of molecular sciences · 2023Article
- Galantamine Based Novel Acetylcholinesterase Enzyme Inhibitors: A Molecular Modeling Design Approach.Molecules (Basel, Switzerland) · 2023Article
- Identification of a Novel Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase: In Vitro and In Silico Studies.Pharmaceuticals (Basel, Switzerland) · 2023Article
- Pharmacological Characteristics of the Hydroethanolic Extract ofEvidence-based complementary and alternative medicine : eCAM · 2023Article
- First Report on the Chemical Composition, Antioxidant Capacity, and Preliminary Toxicity toAntioxidants (Basel, Switzerland) · 2022Article
- Acute Toxicity and Anti-Inflammatory Activity ofMolecules (Basel, Switzerland) · 2022Article
- Studies on the Phytochemical Profile ofInternational journal of molecular sciences · 2022Article
- Phytochemical Profile, Antioxidant Potential and Toxicity Evaluation of the Essential Oils fromAntioxidants (Basel, Switzerland) · 2022Article
- In Silico Evaluation of the Antimicrobial Activity of Thymol-Major Compounds in the Essential Oil ofMolecules (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Kelton L B Dos SantosLaboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, 68902-280 Macapá-AP, Brazil.ORCID 0000-0002-5704-5707
Jorddy N CruzLaboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, 68902-280 Macapá-AP, Brazil.ORCID 0000-0003-0529-3714
Luciane B SilvaLaboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, 68902-280 Macapá-AP, Brazil.
Ryan S RamosLaboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, 68902-280 Macapá-AP, Brazil.ORCID 0000-0003-1802-1320
Moysés F A NetoLaboratory of Molecular Modeling, State University of Feira de Santana, Feira de Santana, 44036-900 Bahia, Brazil.
Cleison C LobatoLaboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, 68902-280 Macapá-AP, Brazil.
Sirlene S B OtaNucleus of Studies and Selection of Bioactive Molecules, Institute of Health Sciences, Federal University of Pará, 66075-110 Belém-PA, Brazil.ORCID 0000-0003-3123-1058
Franco H A LeiteLaboratory of Molecular Modeling, State University of Feira de Santana, Feira de Santana, 44036-900 Bahia, Brazil.ORCID 0000-0003-3166-6051
Rosivaldo S BorgesLaboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, 68902-280 Macapá-AP, Brazil.
Carlos H T P da SilvaComputational Laboratory of Pharmaceutical Chemistry, University of São Paulo, 14040-903 Ribeirão Preto-SP, Brazil.
Joaquín M CamposDepartment of Pharmaceutical and Organic Chemistry, Faculty of Pharmacy, Institute of Biosanitary, Research ibs. Granada, University of Granada, 18071 Granada, Spain.ORCID 0000-0002-9035-8123
Cleydson B R SantosLaboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, 68902-280 Macapá-AP, Brazil.ORCID 0000-0002-0271-335X
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adenosine Receptor Type 2A (A
Indexed as
AdenosineAdenosine A2 Receptor AgonistsHumansLigandsMolecular Docking SimulationMolecular Dynamics SimulationQuantitative Structure-Activity RelationshipReceptors, Adenosine A2AdenosineAdenosine A2 Receptor AgonistsLigandsReceptors, Adenosine A2UK-432097adenosine A2A receptormolecular insightvirtual screening
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.